The DOI matches its Crossref record.
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
Abstract
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily that can be activated by various xenobiotics and natural fatty acids. These transcription factors primarily regulate genes involved in lipid metabolism and also play a role in adipocyte differentiation. We present the expression patterns of the PPAR subtypes in the adult rat, determined by in situ hybridization using specific probes for PPAR-alpha, -beta and -gamma, and by immunohistochemistry using a polyclonal antibody that recognizes the three rat PPAR subtypes. In numerous cell types from either ectodermal, mesodermal, or endodermal origin, PPARs are coexpressed, with relative levels varying between them from one cell type to the other. PPAR-alpha is highly expressed in hepatocytes, cardiomyocytes, enterocytes, and the proximal tubule cells of kidney. PPAR-beta is expressed ubiquitously and often at higher levels than PPAR-alpha and -gamma. PPAR-gamma is expressed predominantly in adipose tissue and the immune system. Our results suggest new potential directions to investigate the functions of the different PPAR subtypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, PPAR-γ is commonly expressed in macrophages and yields anti-inflammatory effects in liver fibrosis.[105]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [105]
Citations
Cited by
Sorted by citations
Items 901–1,000 of 1,005
Hayashi, Y., Ito, Y., Yamagishi, N., Yanagiba, Y., Tamada, H., Wang, D., Ramdhan, D. H., Naito, H., Harada, Y., Kamijima, M., et al. (2011) · Toxicology · doi:10.1016/j.tox.2011.02.007 · Cited by 46
Ibabe, A., Grabenbauer, M., Baumgart‐Vogt, E., Völkl, A., Fahimi, H. D., & Cajaraville, M. P. (2004) · Acta Histochemica · doi:10.1016/j.acthis.2003.09.002 · Cited by 46
Peroxisome proliferator-activated receptor-? as a target for wound healing drugs
Tan, N. S., Michalik, L., Desvergne, B., & Wahli, W. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.1.39 · Cited by 46
Self-citationMaki, T., Maeda, Y., Sonoda, N., Makimura, H., Kimura, S., Maeno, S., Takayanagi, R., & Inoguchi, T. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.013 · Cited by 44
Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back
Schmidt, V., Hogan, A. E., Fallon, P. G., & Schwartz, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932893 · Cited by 51
García-Bates, T. M., Baglole, C. J., Bernard, M. P., Murant, T. I., Simpson‐Haidaris, P. J., & Phipps, R. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900324 · Cited by 45
Wada, E., Koyanagi, S., Kusunose, N., Akamine, T., Masui, H., Hashimoto, H., Matsunaga, N., & Ohdo, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094979 · Cited by 45
Alzheimer’s Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α
Sáez-Orellana, F., Octave, J., & Pierrot, N. (2020) · Cells · doi:10.3390/cells9051215 · Cited by 47
Gene-Gene, Gene-Environment & Multiple Interactions in Colorectal Cancer
Ahmed, F. (2006) · Journal of Environmental Science and Health Part C · doi:10.1080/10590500600614295 · Cited by 45
Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats
Anwer, T., Sharma, M., Pillai, K. K., Haque, S. E., Alam, M. M., & Zaman, M. S. (2006) · Toxicology · doi:10.1016/j.tox.2006.10.016 · Cited by 45
Lunde, I. G., Ekmark, M., Rana, Z. A., Buonanno, A., & Gundersen, K. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.133025 · Cited by 48
Braissant, O., Honegger, P., Loup, M., Iwase, K., Takiguchi, M., & Bachmann, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00274-8 · Cited by 45
Self-citationXiao, Y., Cui, J., Li, Y., Shi, Y., & Le, G. (2010) · Lipids · doi:10.1007/s11745-010-3397-0 · Cited by 44
Díaz‐Gandarilla, J. A., Osorio‐Trujillo, C., Hernández‐Ramírez, V. I., & Talamás‐Rohana, P. (2013) · BioMed Research International · doi:10.1155/2013/215283 · Cited by 44
Luo, S., Huang, Y., Xie, F., Huang, X., Liu, Y., Wang, W.-N., & Qin, Q. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.01.003 · Cited by 44
Wang, Y., Jacome‐Sosa, M. M., Ruth, M. R., Lu, Y., Shen, J., Reaney, M. J. T., Scott, S. L., Dugan, M. E. R., Anderson, H. D., Field, C. J., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100517 · Cited by 44
Mat1 Inhibits Peroxisome Proliferator-Activated Receptor γ-Mediated Adipocyte Differentiation
Helenius, K., Ying, Y., Alasaari, J., & Mäkelä, T. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00347-08 · Cited by 47
López‐León, S., Tuvblad, C., & Forero, D. A. (2016) · Europe PMC (PubMed Central) · doi:10.5604/20831862.1180170 · Cited by 44
PPARγ maintains the metabolic heterogeneity and homeostasis of renal tubules
Lyu, Z., Mao, Z., Li, Q., Xia, Y., Liu, Y., He, Q., Wang, Y., Zhao, H., Lu, Z., & Zhou, Q. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.072 · Cited by 44
Targeting PPARα for the Treatment and Understanding of Cardiovascular Diseases
Li, S., Yang, B., Du, Y., Lin, Y., Liu, J., Huang, S., Zhang, A.-H., Jia, Z., & Zhang, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495969 · Cited by 48
Yang, Q., Kurotani, R., Yamada, A., Kimura, S., & Gonzalez, F. J. (2006) · Endocrinology · doi:10.1210/en.2006-0437 · Cited by 44
PPARγ2Pro12Ala Polymorphism and Human Health
He, W. (2009) · PPAR Research · doi:10.1155/2009/849538 · Cited by 46
Kedees, M. H., Grigoryan, M., Guz, Y., & Teitelman, G. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.024 · Cited by 44
Emerging role of PPAR ligands in the management of diabetic nephropathy
Balakumar, P., Arora, M. K., & Singh, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.010 · Cited by 46
Dolinsky, V. W., Gilham, D., Hatch, G. M., Agellon, L. B., Lehner, R. S., & Vance, D. E. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.09.007 · Cited by 44
Schlezinger, J. J., Howard, G. J., Hurst, C. H., Emberley, J. K., Waxman, D. J., Webster, T. F., & Sherr, D. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3165 · Cited by 44
Defaux, A., Zurich, M., Braissant, O., Honegger, P., & Monnet‐Tschudi, F. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-15 · Cited by 44
Self-citationShimizu, K., Shiratori, K., Kobayashi, M., & Kawamata, H. (2004) · Pancreas · doi:10.1097/00006676-200407000-00058 · Cited by 45
Ishibashi, H., Iwata, H., Kim, E., Lin, T., Kannan, K., Tanabe, S., Batoev, V. B., & Petrov, E. A. (2008) · Environmental Science & Technology · doi:10.1021/es0720558 · Cited by 44
Peroxisome proliferator‐activated receptors are expressed in mouse bone marrow‐derived mast cells
Sugiyama, H., Nonaka, T., Kishimoto, T., Komoriya, K., Tsuji, K., & Nakahata, T. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01169-8 · Cited by 45
Aubert, J., Ailhaud, G. P., & Négrel, R. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01152-0 · Cited by 44
Devchand, P. R., Hihi, A. K., Perroud, M., Schleuning, W.-D. D., Spiegelman, B. M., & Wahli, W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23341 · Cited by 44
Self-citationAlbadrani, H. M., Chauhan, P., Ashique, S., Babu, M. A., Iqbal, D., Almutary, A. G., Abomughaid, M. M., Kamal, M., Paiva‐Santos, A. C., Alsaweed, M., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116376 · Cited by 46
The human peroxisome in health and disease: The story of an oddity becoming a vital organelle
Vamecq, J., Cherkaoui‐Malki, M., Andreoletti, P., & Latruffe, N. (2013) · Biochimie · doi:10.1016/j.biochi.2013.09.019 · Cited by 46
Peroxisome proliferator‐activated receptor‐γ cofactors in neurodegeneration
Katsouri, L., Blondrath, K., & Sastre, M. (2012) · IUBMB Life · doi:10.1002/iub.1097 · Cited by 46
Lee, C. J., Han, J. S., Seo, C., Park, T. H., Kwon, H.-C., Jeong, J., Kim, I. H., Yun, J., Bae, Y., Kwak, J., et al. (2006) · APOPTOSIS · doi:10.1007/s10495-006-4003-z · Cited by 43
Effects of d-α-tocopherol supplements on lipid metabolism in a high-fat diet-fed animal model
Kim, D. Y., Kim, J., Ham, H. J., & Choue, R. (2013) · Nutrition Research and Practice · doi:10.4162/nrp.2013.7.6.481 · Cited by 43
D’Argenio, G., Petillo, O., Margarucci, S., Torpedine, A., Calarco, A., Koverech, A., Boccia, A. S., Paolella, G., & Peluso, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109678 · Cited by 43
Diot, C., & Douaire, M. (1999) · Poultry Science · doi:10.1093/ps/78.8.1198 · Cited by 43
Burdge, G. C., Phillips, E. S., Dunn, R. L., Jackson, A. A., & Lillycrop, K. A. (2004) · Nutrition Research · doi:10.1016/j.nutres.2003.12.009 · Cited by 43
Chang, Y., Chen, Y., Huang, C.-W., Fan, S.-C., Huang, B., Chang, W., Tsai, Y.-S., Su, F., & Wu, C. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00027 · Cited by 43
Berger, J. P., Patel, H. V., Woods, J. W., Hayes, N. S., Parent, S. A., Clemas, J. A., Leibowitz, M. D., Elbrecht, A., Rachubinski, R. A., Capone, J. P., et al. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00211-2 · Cited by 42
Troglitazone does not protect rat pancreatic β cells against free fatty acid-induced cytotoxicity
Cnop, M., Hannaert, J. C., & PIPELEERS, D. G. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00860-2 · Cited by 43
Smith, S. A., Monteith, G. R., Robinson, J. A., Venkata, N. G., May, F. J., & Roberts‐Thomson, S. J. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20153 · Cited by 43
Platelets as a Novel Target for PPAR?? Ligands
Ray, D. M., Spinelli, S. L., Brien, J. J. O., Blumberg, N., & Phipps, R. P. (2006) · BioDrugs · doi:10.2165/00063030-200620040-00004 · Cited by 43
Peroxisome-Proliferator Regulates Key Enzymes of the Tryptophan-NAD+ Pathway
Shin, M., Ohnishi, M., Iguchi, S., Sano, K., & Umezawa, C. Y. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8683 · Cited by 43
Willy, P. J., & Mangelsdorf, D. J. (1998) · Elsevier eBooks · doi:10.1016/b978-012312411-1/50011-1 · Cited by 43
Apostoli, A. J., Skelhorne‐Gross, G., Rubino, R. E., Peterson, N. T., Lena, M. A. D., Schneider, M. M., Sengupta, S., & Nicol, C. J. B. (2013) · International Journal of Cancer · doi:10.1002/ijc.28432 · Cited by 42
Improved insulin sensitivity and islet function after PPARδ activation in diabetic db/db mice
Winzell, M. S., Wulff, E. M., Olsen, G. S., Sauerberg, P., Gotfredsen, C. F., & Åhrén, B. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.053 · Cited by 42
Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice
Barroso, E., del Valle, J., Porquet, D., Santos, A. M. V., Salvadó, L., Rodríguez‐Rodríguez, R., Gutiérrez, P., Anglada‐Huguet, M., Alberch, J., Camins, A., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.006 · Cited by 42
Self-citationFibrates: Therapeutic potential for diabetic nephropathy?
Kouroumichakis, I., Παπάνας, Ν., Zarogoulidis, P., Liakopoulos, V., Maltezos, E. S., & Mikhailidis, D. P. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.12.007 · Cited by 43
PPARα Agonist Oral Therapy in Diabetic Retinopathy
Tomita, Y., Lee, D., Tsubota, K., & Kurihara, T. (2020) · Biomedicines · doi:10.3390/biomedicines8100433 · Cited by 42
PPARγ stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells
Miglio, G., Rattazzi, L., Rosa, A. C., & Fantozzi, R. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.014 · Cited by 43
Biochemical and Physiological Characteristics of Fat Cell.
Kawada, T., Takahashi, N., & Fushiki, T. (2001) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.47.1 · Cited by 42
Martins, K. F., Applegate, B., Hagedorn, B., Kennish, J. M., & Zwollo, P. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.02.037 · Cited by 42
Zhu, H., Fan, C., Xu, F., Tian, C., Zhang, F., & Qi, K. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.07.011 · Cited by 41
Involvement of PPARα and PPARγ in apoptosis and proliferation of human hepatocarcinoma HepG2 cells
Maggiora, M., Oraldi, M., Muzio, G., & Canuto, R. A. (2010) · Cell Biochemistry and Function · doi:10.1002/cbf.1691 · Cited by 42
Lactoferrin suppress the adipogenic differentiation of MC3T3-G2/PA6 cells
Yagi, M., Suzuki, N., Takayama, T., Arisue, M., Kodama, T., Yoda, Y., Numasaki, H., Otsuka, K., & Ito, K. (2008) · Journal of Oral Science · doi:10.2334/josnusd.50.419 · Cited by 42
Emerging roles of PPARδ in metabolism
Seedorf, U., & Aberle, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.017 · Cited by 41
Wahli, W., Devchand, P. R., Jpenberg, A. I., & Desvergne, B. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4861-4_19 · Cited by 44
Self-citationBernardo, A., Ajmone‐Cat, M. A., Levi, G., & Minghetti, L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02045.x · Cited by 45
Thiazolidinediones are associated with a reduced risk of COPD exacerbations
Rinne, S. T., Feemster, L. C., Collins, B. F., Liu, C., Bryson, C. L., O’Riordan, T. G., & Au, D. H. (2015) · International Journal of COPD · doi:10.2147/copd.s82643 · Cited by 41
Duchesne, É., Tremblay, M.-H., & Côt́e, C. H. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-235 · Cited by 41
Tayeb, W., Nakbi, A., Trabelsi, M., Miled, A., & Hammami, M. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.717650 · Cited by 41
Chon, S. J., Kim, S. Y., Cho, N. R., Min, D. L., Hwang, Y. J., & Mamura, M. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.2.352 · Cited by 41
Song, M.-K., Um, J., Jang, H.-J., & Lee, B.-C. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.462 · Cited by 40
Osthol regulates hepatic PPARα-mediated lipogenic gene expression in alcoholic fatty liver murine
Sun, F., Xie, M.-L., Xue, J., & Wang, H.-B. (2009) · Phytomedicine · doi:10.1016/j.phymed.2009.10.021 · Cited by 41
Passaro, A., Nora, E. D., Marcello, C., Vece, F. D., Morieri, M. L., Sanz, J. M., Bosi, C., Fellin, R., & Zuliani, G. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-112 · Cited by 41
Mazzatti, D. J., Smith, M. A., Oita, R. C., Lim, F.-L., White, A., & Reid, M. B. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00281.2007 · Cited by 41
Wei, W., Ma, Z., Xu, S., Zhang, N., & Tang, Q. (2016) · PPAR Research · doi:10.1155/2016/9174190 · Cited by 41
Tiefenbach, J., Magomedova, L., Liu, J., Reunov, A., Tsai, R., Eappen, N. S., Jockusch, R. A., Nislow, C., Cummins, C. L., & Krause, H. M. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.034801 · Cited by 41
Sparsø, T., Hussain, M. S., Andersen, G., Hainerová, I. A., Borch‐Johnsen, K., Jørgensen, T., Hansen, T. F., & Pedersen, O. B. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.10.007 · Cited by 41
Yang, Q., Chen, C., Wu, S., Zhang, Y., Mao, X., & Wang, W. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.025 · Cited by 41
GDF-3 is an adipogenic cytokine under high fat dietary condition
Wang, W., Yang, Y., Meng, Y., & Shi, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.058 · Cited by 41
Mally, P., Mishra, R., Gandhi, S., DeCastro, M., Nankova, B. B., & LaGamma, E. F. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000119365.21770.45 · Cited by 40
GRANT, A., Ortiz-Colón, G., Doumit, M. E., & Buskirk, D. D. (2007) · Journal of Animal Science · doi:10.2527/jas.2007-0379 · Cited by 41
PPARγ as a potential therapeutic target in pulmonary hypertension
Sutliff, R. L., Kang, B., & Hart, C. M. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465809369619 · Cited by 44
Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease
Barak, Y., & Kim, S. (2007) · PPAR Research · doi:10.1155/2007/12781 · Cited by 43
Ishizuka, T., Ito, O., Tan, L., Ogawa, S., Kohzuki, M., Omata, K., Takeuchi, K., & Ito, S. (2003) · Hypertension Research · doi:10.1291/hypres.26.929 · Cited by 41
Komar, C. M., & Curry, T. E. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.5.1531 · Cited by 41
Ide, T., NAKAZAWA, T., Mochizuki, T., & Murakami, K. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80019-0 · Cited by 41
PPARs and Female Reproduction: Evidence from Genetically Manipulated Mice
Yang, J., Chen, L., Zhang, X., Zhou, Y., Zhang, D., Huo, M., & Guan, Y. (2008) · PPAR Research · doi:10.1155/2008/723243 · Cited by 40
Tural, E., Kara, N., Ağaoğlu, S. A., Elbistan, M., Taşmektepligil, M. Y., & İmamoğlu, O. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3453-6 · Cited by 40
Orphan Nuclear Receptors as Targets for Drug Development
Mukherjee, S., & Mani, S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0117-7 · Cited by 42
Raso, G. M., Simeoli, R., Russo, R., Santoro, A. N., Pirozzi, C., Bianca, R. D. D. V., Mitidieri, E., Paciello, O., Pagano, T. B., Orefice, N. S., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.07.007 · Cited by 40
Bility, M. T., Devlin-Durante, M. K., Blazanin, N., Glick, A. B., Ward, J. M., Kang, B. H., Kennett, M. J., Gonzalez, F. J., & Peters, J. M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn219 · Cited by 42
Portilla, D. (1999) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199907000-00012 · Cited by 40
Matheson, J., & Foll, B. L. (2020) · Cells · doi:10.3390/cells9051196 · Cited by 40
Investigational PPAR-γ agonists for the treatment of Type 2 diabetes
Savkur, R. S., & Miller, A. R. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.763 · Cited by 40
Lovekamp-Swan, T., & Chaffin, C. L. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.01.011 · Cited by 40
Dalman, A., Eimani, H., Ashtiani, S. K., Valojerdi, M. R., Eftekhari‐Yazdi, P., Shahverdi, A., & Sepehri, H. (2008) · BioFactors · doi:10.1002/biof.5520330207 · Cited by 40
Freudlsperger, C., Moll, I., Schumacher, U., & Thies, A. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200603000-00011 · Cited by 40
Orfila, C., Lepert, J., Alric, L., Carrera, G., Béraud, M., & Pipy, B. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0785-2 · Cited by 40
Itsuki, A., Kimoto, M., Tsuji, H., HIEMORI, M., & Yamashita, H. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60478 · Cited by 40
Rao, M. S. R. (2002) · Hepatology Research · doi:10.1016/s1386-6346(01)00119-x · Cited by 40
Minge, C. E., Ryan, N. K., der Hoek, K. H. V., Robker, R. L., & Norman, R. J. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.043729 · Cited by 41
Blüher, M., Klemm, T., Gerike, T. G., Krankenberg, H., Schüler, G., & Paschke, R. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460545 · Cited by 40
Cabrero, À., Llaverı́as, G., Roglans, N., Alegret, M., Sánchez, R. M., Adzet, T., Laguna, J. C., & Vázquez‐Carrera, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0926 · Cited by 40
Philp, A., MacKenzie, M. G., Belew, M. Y., Towler, M. C., Corstorphine, A., Papalamprou, A., Hardie, D. G., & Baar, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077200 · Cited by 39
Fibrate treatment for primary biliary cirrhosis
Cuperus, F. J. C., Halilbasic, E., & Trauner, M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000056 · Cited by 36
Metadata
- Authors
- Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1996-01
- Volume
- 137
- Issue
- 1
- Pages
- 354-366
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2047982128
- Cited by
- 2,217
- References
- 0
- Citations by year
- 2026: 14 · 2025: 34 · 2024: 31 · 2023: 32 · 2022: 56 · 2021: 53 · 2020: 50 · 2019: 42 · 2018: 74 · 2017: 64 · 2016: 76 · 2015: 65 · 2014: 75 · 2013: 95 · 2012: 71
- FWCI
- 23.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- peroxisome proliferator-activated receptors, PPARα, PPAR-beta, PPARγ, tissue distribution, nuclear receptors, lipid metabolism, adipogenesis, hepatocytes, cardiomyocytes, enterocytes, proximal tubular epithelial cells, adipose tissue, immune system, rats
- MeSH terms
- Animals, Base Sequence, Female, Male, Molecular Sequence Data, Tissue Distribution, Transcription Factors, Molecular Probes, Rats, Sprague-Dawley, In Situ Hybridization, Receptors, Cytoplasmic and Nuclear, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review